logo

Kaleido Biosciences (KLDO)



Trade KLDO now with
  Date
  Headline
3/24/2021 7:23:07 AM Kaleido Biosciences Reports Positive Results From Non-IND Study Of KB109 In Patients With COVID-19
1/4/2021 7:45:26 AM Kaleido Biosciences Completes Enrollment Of 350 Subjects In Controlled Study Of KB109
10/6/2020 7:44:44 AM Kaleido Biosciences Reports Delay In Timeline For K031 Study; Now Expects Top-line Data In Q1'21
10/1/2020 7:45:05 AM Kaleido Biosciences Names Daniel Menichella President And CEO And Member Of Board
9/29/2020 7:43:21 AM Kaleido Biosciences Announces First Patient Dosed In Clinical Study Of Microbiome Metabolic Therapy KB295
6/1/2020 10:05:51 PM Kaleido Biosciences Prices Public Offering Of 4.75 Mln Shares At $7.50/shr
4/3/2020 8:35:31 AM Kaleido Biosciences Appoints Anne Prener To Board
3/2/2020 7:46:28 AM Kaleido Biosciences Q4 Net Loss $19.5 Mln Or $0.65 Per Share
1/9/2020 8:16:42 AM Kaleido Biosciences Collaborates With Janssen To Explore Potential For Microbiome Metabolic Therapies
9/30/2019 8:04:08 AM Kaleido Biosciences Names Jean Mixer To Its Board
9/9/2019 7:46:01 AM Kaleido Biosciences To Partner With Gustave Roussy Cancer Center
7/15/2019 8:15:32 AM Kaleido Biosciences Names Theo Melas-Kyriazi To Board